dual PKC-thea/delta inhibitors (Zhejiang University/Zhejiang Chinese Medical University/Hangzhou Normal University)

N/A

Report date: 2025/03/18 18:12:12
NME

Base Information

Drug Namedual PKC-thea/delta inhibitors (Zhejiang University/Zhejiang Chinese Medical University/Hangzhou Normal University)
Drug Alias Name7-oxostaurosporine
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C delta inhibitorsProtein kinase C theta inhibitors
TargetsProtein kinase C deltaProtein kinase C theta
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang University
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Normal UniversityZhejiang Chinese Medical UniversityZhejiang University
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A